Drug Search Results
More Filters [+]

MT-3534

Alternative Names: MT-3534, MT 3534, MT3534
Latest Update: 2024-07-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mitsubishi Tanabe
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MT-3534

Countries in Clinic: Japan

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SAD Study

P1

Not yet recruiting

Healthy Volunteers

2025-07-01

jRCT2031240187

P1

Not yet recruiting

Healthy Volunteers

2024-11-30

Recent News Events

Date

Type

Title